Two Cases of Methimazole-Induced Agranulocytosis With Their Risk Factors

Autor: Aye Khine, MD, Kiranjit Dhillon, DO, Linda Jo, DO, Vanessa Wormser, DO, Soe Naing, MD, Shreela Mishra, MD

Publikováno v: AACE Clinical Case Reports, Vol 8, Iss 2, Pp 82-84 (2022)

Background: Antithyroid drugs, such as methimazole (MMI), are standard therapies for the medical management of thyrotoxicosis. Agranulocytosis is a rare but lethal adverse effect of antithyroid medications. We have reported 2 cases of MMI-induced agr

Externí odkaz: https://doaj.org/article/fd6b7629909341bf9352d32f7d0946ea

Clinical outcomes after intracorneal ring segment implantation for keratoconus management in corneas with mild apical haze

Autor: Mohamed Elalfy, Sundas Maqsood, Aja Reinhold, Georgios D. Panos, Aye Khine, Damian Lake, Samer Hamada, Zisis Gatzioufas

Publikováno v: Therapeutic Advances in Ophthalmology, Vol 13 (2021)

Purpose: The implantation of intracorneal ring segments represents an effective and safe therapeutic option for visual improvement in patients with keratoconus. The presence of corneal opacities is considered an exclusion criterion for this operation

Externí odkaz: https://doaj.org/article/ea80c6ea45ae48e9912d8e957555adaa

Active surveillance for congenital rubella syndrome in Yangon, Myanmar

Autor: Thant Kyaw-Zin, Oo Win-Mar, Myint Thein-Thein, Shwe Than-Nu, Han Aye-Maung, Aye Khin-Mar, Aye Kay-Thi, Moe Kyaw, Thein Soe, Robertson Susan E

Publikováno v: Bulletin of the World Health Organization, Vol 84, Iss 1, Pp 12-20 (2006)

OBJECTIVE: Rubella vaccine is not included in the immunization schedule in Myanmar. Although surveillance for outbreaks of measles and rubella is conducted nationwide, there is no routine surveillance for congenital rubella syndrome (CRS). Therefore,

Externí odkaz: https://doaj.org/article/bf841d5830324207af9906d81565beca

Heterogeneity in the prevalence of subclinical malaria, other co-infections and anemia among pregnant women in rural areas of Myanmar: a community-based longitudinal study.

Autor: Aung PP; Department of Health Services Research, CAPHRI, Maastricht University Medical Center, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands. p.aung@maastrichtuniversity.nl.; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA. p.aung@maastrichtuniversity.nl.; Malaria Consortium, Bangkok, Thailand. p.aung@maastrichtuniversity.nl., Han KT; Department of Medical Research, Ministry of Health, Yangon, Myanmar., Groot W; Department of Health Services Research, CAPHRI, Maastricht University Medical Center, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands., Biesma R; Global Health Unit, Department of Health Sciences, University Medical Center Groningen, Groningen, The Netherlands., Thein ZW; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA., Htay T; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA., Lin Z; National Malaria Control Program, Ministry of Health, Mandalay, Myanmar., Aye KH; Department of Medical Research, Ministry of Health, Yangon, Myanmar., Adams M; Malaria Research Program, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA., Pavlova M; Department of Health Services Research, CAPHRI, Maastricht University Medical Center, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.

Publikováno v: Tropical medicine and health [Trop Med Health] 2024 Mar 08; Vol. 52 (1), pp. 22. Date of Electronic Publication: 2024 Mar 08.

G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination.

Autor: Han KT; Mahidol Vivax Research Unit (MVRU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. drkaythwehan@yahoo.com.; Parasitology Research Division, Department of Medical Research (DMR), No. 5 Ziwaka Road, Yangon, 11191, Myanmar. drkaythwehan@yahoo.com., Han ZY; DMR, No. 5 Ziwaka Road, Yangon, 11191, Myanmar., Aye KH; Parasitology Research Division, Department of Medical Research (DMR), No. 5 Ziwaka Road, Yangon, 11191, Myanmar., Wai KT; DMR, No. 5 Ziwaka Road, Yangon, 11191, Myanmar., Thi A; National Malaria Control Program, Department of Public Health (DoPH), Naypyitaw, Myanmar., Cui L; Department of Internal Medicine, University of South Florida, Tampa, USA., Sattabongkot J; Mahidol Vivax Research Unit (MVRU), Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

Publikováno v: Tropical medicine and health [Trop Med Health] 2021 Jun 09; Vol. 49 (1), pp. 47. Date of Electronic Publication: 2021 Jun 09.